Guardant Health, Inc. (NASDAQ:GH) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the nineteen analysts that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $89.00.
Several equity analysts recently weighed in on the stock. BTIG Research cut their price objective on shares of Guardant Health from $80.00 to $60.00 in a research report